Literature DB >> 27079372

The role of adiponectin in obesity-associated female-specific carcinogenesis.

Ganji Purnachandra Nagaraju1, Balney Rajitha2, Sheik Aliya3, Rama P Kotipatruni4, Appiya Santharam Madanraj5, Anthea Hammond6, Dongkyoo Park7, Srinivasulu Chigurupati8, Afroz Alam9, Subasini Pattnaik10.   

Abstract

Adipose tissue is a highly vascularized endocrine organ, and its secretion profiles may vary with obesity. Adiponectin is secreted by adipocytes that make up adipose tissue. Worldwide, obesity has been designated a serious health problem among women and is associated with a variety of metabolic disorders and an increased risk of developing cancer of the cervix, ovaries, uterus (uterine/endometrial), and breast. In this review, the potential link between obesity and female-specific malignancies is comprehensively presented by discussing significant features of the intriguing and complex molecule, adiponectin, with a focus on recent findings highlighting its molecular mechanism of action in female-specific carcinogenesis.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adiponectin; Breast cancer; Cervical cancer; Endometrial cancer; Obesity; Ovarian cancer

Mesh:

Substances:

Year:  2016        PMID: 27079372     DOI: 10.1016/j.cytogfr.2016.03.014

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  17 in total

Review 1.  Regulation of aromatase in cancer.

Authors:  Deborah Molehin; Fahmida Rasha; Rakhshanda Layeequr Rahman; Kevin Pruitt
Journal:  Mol Cell Biochem       Date:  2021-02-18       Impact factor: 3.396

Review 2.  Signals from the Adipose Microenvironment and the Obesity-Cancer Link-A Systematic Review.

Authors:  Caroline Himbert; Mahmoud Delphan; Dominique Scherer; Laura W Bowers; Stephen Hursting; Cornelia M Ulrich
Journal:  Cancer Prev Res (Phila)       Date:  2017-09

Review 3.  Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin.

Authors:  Jing Li; Xiaoxin Luke Chen; Anisa Shaker; Tadayuki Oshima; Jing Shan; Hiroto Miwa; Cheng Feng; Jun Zhang
Journal:  Ann N Y Acad Sci       Date:  2016-07-21       Impact factor: 5.691

Review 4.  Emerging role of adipokines in systemic lupus erythematosus.

Authors:  Hong-Miao Li; Tian-Ping Zhang; Rui-Xue Leng; Xiang-Pei Li; Xiao-Mei Li; Hai-Rong Liu; Dong-Qing Ye; Hai-Feng Pan
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

5.  Adiponectin, Leptin, and Insulin-Pathway Receptors as Endometrial Cancer Subtyping Markers.

Authors:  Evan L Busch; Marta Crous-Bou; Jennifer Prescott; Michael J Downing; Bernard A Rosner; George L Mutter; Immaculata De Vivo
Journal:  Horm Cancer       Date:  2018-01-02       Impact factor: 3.869

Review 6.  A Functional Interplay between IGF-1 and Adiponectin.

Authors:  Stefania Orrù; Ersilia Nigro; Annalisa Mandola; Andreina Alfieri; Pasqualina Buono; Aurora Daniele; Annamaria Mancini; Esther Imperlini
Journal:  Int J Mol Sci       Date:  2017-10-14       Impact factor: 5.923

7.  Expression of Adiponectin Receptor-1 and Prognosis of Epithelial Ovarian Cancer Patients.

Authors:  Xiahui Li; Zhe Yu; Liping Fang; Fang Liu; Kui Jiang
Journal:  Med Sci Monit       Date:  2017-03-30

8.  Adverse effect of excess body weight on survival in cervical cancer patients after surgery and radiotherapy.

Authors:  Yunseon Choi; Ki Jung Ahn; Sung Kwang Park; Heunglae Cho; Ji Young Lee
Journal:  Radiat Oncol J       Date:  2016-12-22

Review 9.  Serum adiponectin in breast cancer: A meta-analysis.

Authors:  Li Gu; Chang Cao; Jing Fu; Qian Li; De-Hua Li; Ming-Yao Chen
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

10.  Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet.

Authors:  Chian-Jiun Liou; Yau-Ker Lee; Nai-Chun Ting; Ya-Ling Chen; Szu-Chuan Shen; Shu-Ju Wu; Wen-Chung Huang
Journal:  Cells       Date:  2019-05-11       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.